SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-046457
Filing Date
2019-12-20
Accepted
2019-12-20 09:00:53
Documents
11
Period of Report
2019-12-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K achv-8k_20191217.htm 8-K 51257
2 EX-1.1 achv-ex11_11.htm EX-1.1 546732
3 EX-3.1 achv-ex31_9.htm EX-3.1 131228
4 EX-4.1 achv-ex41_10.htm EX-4.1 153007
5 EX-4.2 achv-ex42_77.htm EX-4.2 6220
6 EX-99.1 achv-ex991_55.htm EX-99.1 14635
7 EX-99.2 achv-ex992_30.htm EX-99.2 13503
8 GRAPHIC gb1qb0enwkww000001.jpg GRAPHIC 68529
9 GRAPHIC gqvm4sakt3ca000001.jpg GRAPHIC 18627
10 GRAPHIC greuhe542dt4000001.jpg GRAPHIC 18627
11 GRAPHIC gb1qb0enwkww000002.jpg GRAPHIC 62648
  Complete submission text file 0001564590-19-046457.txt   1150320
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 191297773
SIC: 2835 In Vitro & In Vivo Diagnostic Substances